The first breakthrough emerged from a study testing the hypothesis that candidate inborn errors of TLR3-, IRF7-, and IRF9-dependent type I IFN immunity previously shown to underlie life-threatening influenza pneumonia (2, 23, 24, 30, 31, 61–64) might also underlie critical COVID-19. Here, TLR3 is linked to pneumonia.